Imatinib and myelodysplastic syndrome Patient Reports February 11, 2012

Imatinib Side Effects Report #4617250-1
Imatinib side effect was reported by a Health Professional from on Mar 17, 2005. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, myelodysplastic syndrome. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #4617249-5
Imatinib side effect was reported by a Health Professional from on Mar 17, 2005. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, myelodysplastic syndrome. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5375885-5
Imatinib side effect was reported by a Health Professional from AUSTRALIA on June 27, 2007. Female patient, 56 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow failure, chromosome analysis abnormal, chronic myeloid leukaemia, dysplasia, macrocytosis, malignant neoplasm progression, myelodysplastic syndrome, myeloid maturation arrest. Imatinib dosage: 400 MG/D. Patient died.

Imatinib Side Effects Report #5128465-0
Imatinib side effect was reported by a Physician from UNITED STATES on Oct 09, 2006. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast cell proliferation, myelodysplastic syndrome, thrombocytopenia. Imatinib dosage: 800 MG/D. Patient died on 01/01/2006.


Imatinib Side Effects Report #5430651-7
Imatinib side effect was reported by a Consumer or non-health professional from SPAIN on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.

Imatinib Side Effects Report #4883596-5
Imatinib side effect was reported by a Physician from SPAIN on Jan 06, 2006. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #6094605-2
Imatinib side effect was reported by a Health Professional from GERMANY on Feb 17, 2009. Female patient, 52 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cells present, cytogenetic analysis abnormal, gene mutation identification test positive, leukaemia recurrent, myelodysplastic syndrome. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5129360-3
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2006. Female patient, 51 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell proliferation, chromosome analysis abnormal, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 400 MG/DAY. Patient died.

Imatinib Side Effects Report #4883570-9
Imatinib side effect was reported by a Physician from UNITED STATES on Jan 06, 2006. Female patient, 51 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast cell proliferation, chromosome analysis abnormal, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 400 MG/DAY. Patient recovered.


Imatinib Side Effects Report #5874478-0
Imatinib side effect was reported by a Health Professional from JAPAN on May 30, 2008. Male patient, 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, haemoglobin decreased, myelodysplastic syndrome, white blood cell count decreased. Imatinib dosage: 600 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5477895-6
Imatinib side effect was reported by a Health Professional from CANADA on Sept 28, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, cytogenetic abnormality, myelodysplastic syndrome, perianal abscess. Imatinib dosage: 400 MG/D. During the same period patient was treated with HYDROXYUREA. Patient recovered.

Imatinib Side Effects Report #5608989-X
Imatinib side effect was reported by a Health Professional from MALTA on Jan 25, 2008. Male patient was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, bone marrow failure, gastrointestinal haemorrhage, lung infection, malignant neoplasm progression, myelodysplastic syndrome, pancytopenia, pulmonary haemorrhage, thrombocytopenia. Imatinib dosage: 600 MG/D. Patient died.

Imatinib Side Effects Report #5693247-8
Imatinib side effect was reported by a Health Professional from UNITED STATES on Mar 25, 2008. Female patient, 62 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, cytogenetic abnormality, fluid retention, malignant neoplasm progression, monocytosis, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 600 MG/D. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE, PREDNISONE. Patient recovered.

Imatinib Side Effects Report #5823157-4
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 17, 2008. Female patient, 62 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, cytogenetic abnormality, fluid retention, malignant neoplasm progression, monocytosis, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 600 MG/D. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE, PREDNISONE. Patient recovered.